Augmentation of NZB autoimmune phenotypes by the Sle1c murine lupus susceptibility interval

Journal of Immunology

Volumn 178, Issue 7, 2007, Pages 4667-4675

  Giles, Brendan M ^a   Tchepeleva, Svetlana N ^a   Kachinski, Julie J ^a   Ruff, Katherine ^a   Croker, Byron P ^b,c   Morel, Laurence ^b   Boackle, Susan A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DNA ANTIBODY; IMMUNOGLOBULIN G; NITROGEN; PROTEIN DERIVATIVE; PROTEIN SLE1C; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHROMOSOME 1; COMPLEMENT DEPOSITION; CONGENIC STRAIN; CONTROLLED STUDY; CR2 GENE; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GLOMERULONEPHRITIS; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; NZB GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL;

EID: 33947626703     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.7.4667     Document Type: Article

References (29)

1. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408.
2. Z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice: origins and initial characterization. Lab. Invest. 68: 419-426.
3. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229.
4. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7: 335-339.
5. Mohan, C., E. Alas, L. Morel, P. Yang, and E. K. Wakeland. 1998. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101: 1362-1372.
6. Mohan, C., L. Morel, P. Yang, and E. K. Wakeland. 1997. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159: 454-465.
7. Mohan, C., L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson, and E. K. Wakeland. 1999. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103: 1685-1695.
8. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97: 6670-6675.
9. Morel, L., K. R. Blenman, B. P. Croker, and E. K. Wakeland. 2001. The major murine SLE-susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. USA 98: 1787-1792.
10. Boackle, S. A., V. M. Holers, X. Chen, G. Szakonyi, D. R. Karp, E. K. Wakeland, and L. Morel. 2001. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15: 775-785.
11. Croker, B. P., G. Gilkeson, and L. Morel. 2003. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun. 4: 575-585.
12. Rozzo, S. J., T. J. Vyse, C. G. Drake, and B. L. Kotzin. 1996. Effect of genetic background on the contribution of New Zealand Black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA 93: 15164-15168.
13. Rozzo, S. J., S. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15: 435-443.
14. Pirani, C. L., and B. Croker. 1994. Handling and Processing of Renal Biopsy and Nephrectomy Specimens. J. B. Lippincott, Philadelphia, PA.
15. Henson, S. E., D. Smith, S. A. Boackle, V. M. Holers, and D. R. Karp. 2001. Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J. Immunol. Methods 258: 97-109.
16. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141: 457-463.
17. Waters, S. T., S. M. Fu, F. Gaskin, U. S. Deshmukh, S.-S. J. Sung, C. C. Kannapell, K. S. K. Tung, S. B. McEwen, and M. McDuffie. 2001. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100: 372-383.
18. Jiang, C., F. Gaskin, Y. Ge, and S. M. Fu. 2005. Genetic analysis of SLE susceptibility genes conferring ANA and anti-dsDNA autoantibody production, acute and chronic glomerulonephritis. Arthritis Rheum. 52: S628.
19. Fulpius, T., F. Spertini, L. Reininger, and S. Izui. 1993. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc. Natl. Acad. Sci. USA 90: 2345-2349.
20. Izui, S., T. Fulpius, L. Reininger, Y. Pastore, and T. Kobayakawa. 1998. Role of neutrophils in murine cryoglobulinemia. lnflamm. Res. 47(Suppl. 3): S145-S150.
21. Chen, Y., D. Perry, S. A. Boackle, E. S. Sobel, H. Molina, B. P. Croker, and L. Morel. 2005. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J. Immunol. 175: 1080-1089.
22. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse Complement Receptor 1 (CR1) and Crry, the two genetic homologs of human CR1. J. Exp. Med. 175: 121-129.
23. Fingeroth, J. D., M. E. Heath, and D. M. Ambrosino. 1989. Proliferation of resting B cells is modulated by CR2 and CR1. Immunol. Lett. 21: 291-302.
24. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153: 4448-4457.
25. Klaus, G. G. B. 1978. The generation of memory cells, II: generation of B memory cells with preformed antigen-antibody complexes. Immunology 34: 643-652.
26. Papamichai, M., C. Gutierrez, P. Embling, P. Johnson, E. J. Holborow, and M. B. Pepys. 1975. Complement dependence of localization of aggregated IgG in germinal centers. Scand. J. Immunol. 4: 343-347.
27. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151: 4295-4305.
28. Lee, Y. H., H. Wu, R. M. Cantor, J. M. Grossman, A. A. Rumbin, E. Park, N. Shen, C. J. Chen, H. M. Badsha, B. Y. H. Thong, et al. 2004. Evidence for SLE susceptibility gene(s) at 1q32. Arthritis Rheum. 50: S607.
29. Bagavant, H., U. S. Deshmukh, F. Gaskin, and S. M. Fu. 2004. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand. J. Immunol. 60: 52-63.